745
Views
19
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Safety of tocilizumab in the treatment of juvenile idiopathic arthritis

&
Pages 493-500 | Received 24 Nov 2016, Accepted 03 Mar 2017, Published online: 22 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rolando Cimaz, Gabriella Maioli & Giulia Calabrese. (2020) Current and emerging biologics for the treatment of juvenile idiopathic arthritis. Expert Opinion on Biological Therapy 20:7, pages 725-740.
Read now
Shinji Akioka. (2019) Interleukin-6 in juvenile idiopathic arthritis. Modern Rheumatology 29:2, pages 275-286.
Read now

Articles from other publishers (17)

Gianluca Dini, Giovanni Battista Dell’Isola, Alfredo Beccasio, Giuseppe Di Cara, Alberto Verrotti & Carlo Cagini. (2022) Biologic therapies for juvenile idiopathic arthritis-associated uveitis. Frontiers in Ophthalmology 2.
Crossref
Lina N. Zaripova, Angela Midgley, Stephen E. Christmas, Michael W. Beresford, Eileen M. Baildam & Rachel A. Oldershaw. (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatric Rheumatology 19:1.
Crossref
Cecília Anatriello dos Santos, Luana Coelho Benevides, Renata Nahas Cardili, Gecilmara Cristina Salviato Pileggi, Virginia Paes Leme Ferriani & Ana Maria Ferreira Roselino. (2021) Malignant Syphilis in a Young Patient With Juvenile Idiopathic Arthritis Under Biological Therapy. JCR: Journal of Clinical Rheumatology 27:8S, pages S382-S383.
Crossref
Annalisa Marcuzzi, Elisabetta Melloni, Giorgio Zauli, Arianna Romani, Paola Secchiero, Natalia Maximova & Erika Rimondi. (2021) Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity. International Journal of Molecular Sciences 22:20, pages 11241.
Crossref
Tobias Zrzavy, Isabella Wimmer, Paulus S. Rommer & Thomas Berger. (2020) Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown. European Journal of Neurology 28:10, pages 3503-3516.
Crossref
Elnaz Roohi, Nematollah Jaafari & Farshad Hashemian. (2021) On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?. Journal of Neuroinflammation 18:1.
Crossref
Izabela Woś & Jacek Tabarkiewicz. (2021) Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis. Immunologic Research 69:1, pages 26-42.
Crossref
Adrien Schvartz, Alexandre Belot & Isabelle Kone-Paut. (2020) Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic. Frontiers in Pediatrics 8.
Crossref
Meng Xu, Congcong Liu, Lishuang Guo & Sirui Yang. (2020) Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report. BMC Pediatrics 20:1.
Crossref
Arielle Sasson, Amna Aijaz, Svetlana Chernyavsky & Nadim Salomon. (2020) A Coronavirus Disease 2019 (COVID-19) Mystery: Persistent Fevers and Leukocytosis in a Patient With Severe COVID-19. Open Forum Infectious Diseases 7:12.
Crossref
Ekaterina I. Alexeeva, Dariya D. Vankova, Tatyana M. DvoryakovskayaKsenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomakhidze, Tatyana V. Radygina, Irina V. Zubkova, Natalia E. Tkachenko, Anna N. Fetisova, Olga L. Lomakina, Yanina O. Orlova, Mariya K. Kurdup, Marina S. Gautier, Elizaveta A. Krekhova, Meyri S. Shingarova & Olga P. Galkina. (2020) Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study. Current Pediatrics 19:3, pages 190-199.
Crossref
Alexandra Laberko, Daria Yukhacheva, Yulia Rodina, Dmitriy Abramov, Dmitriy Konovalov, Svetlana Radygina, Larisa Shelikhova, Dmitry Pershin, Olga Kadnikova, Michael Maschan, Alexei Maschan, Dmitry Balashov & Anna Shcherbina. (2020) BCG-Related Inflammatory Syndromes in Severe Combined Immunodeficiency After TCRαβ+/CD19+ Depleted HSCT. Journal of Clinical Immunology 40:4, pages 625-636.
Crossref
Fatma Yazılıtaş, Semanur Özdel, Doğan Şimşek, Özlem Aydoğ, Evrim Kargın Çakıcı, Gökçe Gür Can, Tülin Güngör & Mehmet Bülbül. (2019) Tocilizumab for juvenile idiopathic arthritis: a single-center case series. Sao Paulo Medical Journal 137:6, pages 517-522.
Crossref
Ekaterina I. Alekseeva, Dar’ya D. Van’kova, Tatyana M. DvoryakovskayaKseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko, Maria V. Kurdup, Tatyana V. Radygina & Irina V. Zubkova. (2019) 13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case. Current Pediatrics 18:3, pages 180-186.
Crossref
Ekaterina I. Alekseeva, Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. DvoryakovskayaKseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy & Natalya E. Tkachenko. (2019) Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review. Current Pediatrics 18:2, pages 101-108.
Crossref
Grace Y. Gombolay & Tanuja Chitnis. (2018) Pediatric Neuromyelitis Optica Spectrum Disorders. Current Treatment Options in Neurology 20:6.
Crossref
Rolando Cimaz, Achille Marino & Alberto Martini. (2017) How I treat juvenile idiopathic arthritis: A state of the art review. Autoimmunity Reviews 16:10, pages 1008-1015.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.